These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2805946)

  • 21. [The pathological anatomy of pemphigus in connection with its treatment with steroid hormones].
    Vasil'eva NN
    Arkh Patol; 1968; 30(6):45-51. PubMed ID: 4301202
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus.
    Queale WS; Seidler AJ; Brancati FL
    Arch Intern Med; 1997 Mar; 157(5):545-52. PubMed ID: 9066459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of steroid-induced diabetes mellitus in leprosy.
    Papang R; John AS; Abraham S; Rao PS
    Indian J Lepr; 2009; 81(3):125-9. PubMed ID: 20509340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up.
    Liao YN; Liu CS; Tsai TR; Hung YC; Chang SJ; Lin HL; Chen YC; Lai HM; Yu SF; Chen CJ
    Kaohsiung J Med Sci; 2011 Jul; 27(7):251-7. PubMed ID: 21757141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Glucocorticoids and diabetes mellitus].
    Vondra K; Hampl R
    Vnitr Lek; 2006 May; 52(5):493-7. PubMed ID: 16771098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experience in continuous administration of insulin using infusion dispenser at a metabolic intensive care unit (MICU)].
    Charvát J; Pálová S; Horácková M; Kratochvíl J; Masopust J
    Vnitr Lek; 2007 Oct; 53(10):1047-52. PubMed ID: 18072428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intentions of systemic glucocorticoid (GC) therapy].
    Goerz G
    Arch Dermatol Forsch; 1972; 244():400-3. PubMed ID: 4648731
    [No Abstract]   [Full Text] [Related]  

  • 30. [Non-ketotic hyperosmolar diabetic coma in neurosurgical cases; review of 7 cases].
    Matsumura A; Shinohara A; Hashikawa M; Kukita C; Komatsu Y; Takano S; Maki Y
    No Shinkei Geka; 1990 Jan; 18(1):33-8. PubMed ID: 2406636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes--results of a hyperglycaemic glucose clamp study.
    Rave K; Nosek L; Posner J; Heise T; Roggen K; van Hoogdalem EJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2166-71. PubMed ID: 16627603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for steroid diabetes in rheumatic patients.
    Raúl Ariza-Andraca C; Barile-Fabris LA; Frati-Munari AC; Baltazár-Montufar P
    Arch Med Res; 1998; 29(3):259-62. PubMed ID: 9775461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
    Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
    Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Certain complications of corticosteroid therapy].
    Aleksandrova EP; Somskova TV
    Klin Med (Mosk); 1973 Dec; 51(12):94-7. PubMed ID: 4779028
    [No Abstract]   [Full Text] [Related]  

  • 36. [Insulin sensitivity and beta cell function in female systemic lupus erythematosus patients].
    Zeng YJ; Zeng FQ; Dai L; Yang C; Lin BZ; Zheng DH; Liu CW; Liu D; Yan L; Cheng H
    Zhonghua Nei Ke Za Zhi; 2011 Jan; 50(1):18-22. PubMed ID: 21418882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic pancreatitis and diabetes].
    Petrin P; Chiappetta A; Del Favero G; Farini R; Pedrazzoli S
    Minerva Med; 1983 Jan; 74(1-2):31-8. PubMed ID: 6337349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carbohydrate metabolism disorders in pemphigus patients treated with steroid hormones].
    Madievskaia NN; Golovko LN
    Vestn Dermatol Venerol; 1972 Jun; 46(6):13-6. PubMed ID: 5052781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.